Sandoz Settlement Sets Date For US Denosumab Entry

Deal With Amgen Ends Litigation, Allowing Prolia/Xgeva Biosimilars To Launch Next Year

May 2025 calendar
Sandoz will be able to launch in May 2025 • Source: Shutterstock

More from Deals

More from Business